Dharmaraj Neeraja, Reddy Aramati, Kiran Velamakanni, Mandal Anil, Panicker Shirly, Chakrabarti Subhabrata
Brien Holden Eye Research Centre, Hyderabad Eye Research Foundation, Hyderabad, India.
Ophthalmic Genet. 2003 Sep;24(3):161-5. doi: 10.1076/opge.24.3.161.15607.
In order to understand the underlying molecular genetic defect causing aniridia in India, eight probands from sporadic cases were screened for all 14 exons of the PAX6 gene using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Direct sequencing of the SSCP variants revealed a nonsense mutation (R317X) in the eleventh exon leading to a premature termination of the PAX6 protein in the proline-serine-threonine (PST)-rich domain in two probands. Another proband exhibited an intronic polymorphism (IVS 9-12 C-T). The mutation resulted in loss of function of the PAX6 protein along with variable phenotypic manifestations in the probands. This is the first report describing a PAX6 gene mutation in aniridia cases from India and highlights the variable expressivity in phenotypes due to haploinsufficiency.
为了解导致印度无虹膜症的潜在分子遗传缺陷,利用聚合酶链反应-单链构象多态性(PCR-SSCP)技术,对来自散发病例的8名先证者的PAX6基因的全部14个外显子进行了筛查。对SSCP变异体进行直接测序后发现,两名先证者的第11外显子存在无义突变(R317X),导致PAX6蛋白在富含脯氨酸-丝氨酸-苏氨酸(PST)的结构域中提前终止。另一名先证者表现出内含子多态性(IVS 9-12 C-T)。该突变导致PAX6蛋白功能丧失,同时在先证者中出现了不同的表型表现。这是首篇描述印度无虹膜症病例中PAX6基因突变的报告,并突出了由于单倍体不足导致的表型可变表达。